Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis

Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Saori Nagashima [verfasserIn] Mayu Yamamoto [verfasserIn] Yusuke Inuzuka [verfasserIn] Makoto Irahara [verfasserIn] Yumiko Miyaji [verfasserIn] Hiromi Tadaki [verfasserIn] Shuichi Ito [verfasserIn] Shizuka Masuda [verfasserIn] Yoshiyuki Ito [verfasserIn] Yuri Saito [verfasserIn] Saeko Kobayashi [verfasserIn] Hideaki Morita [verfasserIn] Takako Yoshioka [verfasserIn] Hirotaka Shimizu [verfasserIn] Katsuhiro Arai [verfasserIn] Yukihiro Ohya [verfasserIn] Hirohisa Saito [verfasserIn] Kenji Matsumoto [verfasserIn] Ichiro Nomura [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2023

Schlagwörter:	Eosinophilic duodenitis (EoD) Eosinophilic gastrointestinal disorders (EGID, EGIDs) Eosinophilic gastritis (EoG) Elimination diet (ED) Non-IgE-mediated gastrointestinal food allergy

Übergeordnetes Werk:	In: Allergology International - Elsevier, 2002, 72(2023), 2, Seite 306-315
Übergeordnetes Werk:	volume:72 ; year:2023 ; number:2 ; pages:306-315

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.1016/j.alit.2022.11.001

Katalog-ID:	DOAJ088827224

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ088827224
003	DE-627
005	20230501183740.0
007	cr uuu---uuuuu
008	230410s2023 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/j.alit.2022.11.001 \|2 doi
035			\|a (DE-627)DOAJ088827224
035			\|a (DE-599)DOAJ900b9bc74c4646cabf2df89ae6f8dd96
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RC581-607
100	0		\|a Saori Nagashima \|e verfasserin \|4 aut
245	1	0	\|a Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis
264		1	\|c 2023
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs.
650		4	\|a Eosinophilic duodenitis (EoD)
650		4	\|a Eosinophilic gastrointestinal disorders (EGID, EGIDs)
650		4	\|a Eosinophilic gastritis (EoG)
650		4	\|a Elimination diet (ED)
650		4	\|a Non-IgE-mediated gastrointestinal food allergy
653		0	\|a Immunologic diseases. Allergy
700	0		\|a Mayu Yamamoto \|e verfasserin \|4 aut
700	0		\|a Yusuke Inuzuka \|e verfasserin \|4 aut
700	0		\|a Makoto Irahara \|e verfasserin \|4 aut
700	0		\|a Yumiko Miyaji \|e verfasserin \|4 aut
700	0		\|a Hiromi Tadaki \|e verfasserin \|4 aut
700	0		\|a Shuichi Ito \|e verfasserin \|4 aut
700	0		\|a Shizuka Masuda \|e verfasserin \|4 aut
700	0		\|a Yoshiyuki Ito \|e verfasserin \|4 aut
700	0		\|a Yuri Saito \|e verfasserin \|4 aut
700	0		\|a Saeko Kobayashi \|e verfasserin \|4 aut
700	0		\|a Hideaki Morita \|e verfasserin \|4 aut
700	0		\|a Takako Yoshioka \|e verfasserin \|4 aut
700	0		\|a Hirotaka Shimizu \|e verfasserin \|4 aut
700	0		\|a Katsuhiro Arai \|e verfasserin \|4 aut
700	0		\|a Yukihiro Ohya \|e verfasserin \|4 aut
700	0		\|a Hirohisa Saito \|e verfasserin \|4 aut
700	0		\|a Kenji Matsumoto \|e verfasserin \|4 aut
700	0		\|a Ichiro Nomura \|e verfasserin \|4 aut
773	0	8	\|i In \|t Allergology International \|d Elsevier, 2002 \|g 72(2023), 2, Seite 306-315 \|w (DE-627)320425320 \|w (DE-600)2003098-8 \|x 14401592 \|7 nnns
773	1	8	\|g volume:72 \|g year:2023 \|g number:2 \|g pages:306-315
856	4	0	\|u https://doi.org/10.1016/j.alit.2022.11.001 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/900b9bc74c4646cabf2df89ae6f8dd96 \|z kostenfrei
856	4	0	\|u http://www.sciencedirect.com/science/article/pii/S1323893022001265 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1323-8930 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 72 \|j 2023 \|e 2 \|h 306-315

Indexfelder

author_variant	s n sn m y my y i yi m i mi y m ym h t ht s i si s m sm y i yi y s ys s k sk h m hm t y ty h s hs k a ka y o yo h s hs k m km i n in
matchkey_str	article:14401592:2023----::oeaiiynsftoaeeiiainitopdarcoiohlc
hierarchy_sort_str	2023
callnumber-subject-code	RC
publishDate	2023
allfields	10.1016/j.alit.2022.11.001 doi (DE-627)DOAJ088827224 (DE-599)DOAJ900b9bc74c4646cabf2df89ae6f8dd96 DE-627 ger DE-627 rakwb eng RC581-607 Saori Nagashima verfasserin aut Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs. Eosinophilic duodenitis (EoD) Eosinophilic gastrointestinal disorders (EGID, EGIDs) Eosinophilic gastritis (EoG) Elimination diet (ED) Non-IgE-mediated gastrointestinal food allergy Immunologic diseases. Allergy Mayu Yamamoto verfasserin aut Yusuke Inuzuka verfasserin aut Makoto Irahara verfasserin aut Yumiko Miyaji verfasserin aut Hiromi Tadaki verfasserin aut Shuichi Ito verfasserin aut Shizuka Masuda verfasserin aut Yoshiyuki Ito verfasserin aut Yuri Saito verfasserin aut Saeko Kobayashi verfasserin aut Hideaki Morita verfasserin aut Takako Yoshioka verfasserin aut Hirotaka Shimizu verfasserin aut Katsuhiro Arai verfasserin aut Yukihiro Ohya verfasserin aut Hirohisa Saito verfasserin aut Kenji Matsumoto verfasserin aut Ichiro Nomura verfasserin aut In Allergology International Elsevier, 2002 72(2023), 2, Seite 306-315 (DE-627)320425320 (DE-600)2003098-8 14401592 nnns volume:72 year:2023 number:2 pages:306-315 https://doi.org/10.1016/j.alit.2022.11.001 kostenfrei https://doaj.org/article/900b9bc74c4646cabf2df89ae6f8dd96 kostenfrei http://www.sciencedirect.com/science/article/pii/S1323893022001265 kostenfrei https://doaj.org/toc/1323-8930 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 72 2023 2 306-315
spelling	10.1016/j.alit.2022.11.001 doi (DE-627)DOAJ088827224 (DE-599)DOAJ900b9bc74c4646cabf2df89ae6f8dd96 DE-627 ger DE-627 rakwb eng RC581-607 Saori Nagashima verfasserin aut Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs. Eosinophilic duodenitis (EoD) Eosinophilic gastrointestinal disorders (EGID, EGIDs) Eosinophilic gastritis (EoG) Elimination diet (ED) Non-IgE-mediated gastrointestinal food allergy Immunologic diseases. Allergy Mayu Yamamoto verfasserin aut Yusuke Inuzuka verfasserin aut Makoto Irahara verfasserin aut Yumiko Miyaji verfasserin aut Hiromi Tadaki verfasserin aut Shuichi Ito verfasserin aut Shizuka Masuda verfasserin aut Yoshiyuki Ito verfasserin aut Yuri Saito verfasserin aut Saeko Kobayashi verfasserin aut Hideaki Morita verfasserin aut Takako Yoshioka verfasserin aut Hirotaka Shimizu verfasserin aut Katsuhiro Arai verfasserin aut Yukihiro Ohya verfasserin aut Hirohisa Saito verfasserin aut Kenji Matsumoto verfasserin aut Ichiro Nomura verfasserin aut In Allergology International Elsevier, 2002 72(2023), 2, Seite 306-315 (DE-627)320425320 (DE-600)2003098-8 14401592 nnns volume:72 year:2023 number:2 pages:306-315 https://doi.org/10.1016/j.alit.2022.11.001 kostenfrei https://doaj.org/article/900b9bc74c4646cabf2df89ae6f8dd96 kostenfrei http://www.sciencedirect.com/science/article/pii/S1323893022001265 kostenfrei https://doaj.org/toc/1323-8930 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 72 2023 2 306-315
allfields_unstemmed	10.1016/j.alit.2022.11.001 doi (DE-627)DOAJ088827224 (DE-599)DOAJ900b9bc74c4646cabf2df89ae6f8dd96 DE-627 ger DE-627 rakwb eng RC581-607 Saori Nagashima verfasserin aut Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs. Eosinophilic duodenitis (EoD) Eosinophilic gastrointestinal disorders (EGID, EGIDs) Eosinophilic gastritis (EoG) Elimination diet (ED) Non-IgE-mediated gastrointestinal food allergy Immunologic diseases. Allergy Mayu Yamamoto verfasserin aut Yusuke Inuzuka verfasserin aut Makoto Irahara verfasserin aut Yumiko Miyaji verfasserin aut Hiromi Tadaki verfasserin aut Shuichi Ito verfasserin aut Shizuka Masuda verfasserin aut Yoshiyuki Ito verfasserin aut Yuri Saito verfasserin aut Saeko Kobayashi verfasserin aut Hideaki Morita verfasserin aut Takako Yoshioka verfasserin aut Hirotaka Shimizu verfasserin aut Katsuhiro Arai verfasserin aut Yukihiro Ohya verfasserin aut Hirohisa Saito verfasserin aut Kenji Matsumoto verfasserin aut Ichiro Nomura verfasserin aut In Allergology International Elsevier, 2002 72(2023), 2, Seite 306-315 (DE-627)320425320 (DE-600)2003098-8 14401592 nnns volume:72 year:2023 number:2 pages:306-315 https://doi.org/10.1016/j.alit.2022.11.001 kostenfrei https://doaj.org/article/900b9bc74c4646cabf2df89ae6f8dd96 kostenfrei http://www.sciencedirect.com/science/article/pii/S1323893022001265 kostenfrei https://doaj.org/toc/1323-8930 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 72 2023 2 306-315
allfieldsGer	10.1016/j.alit.2022.11.001 doi (DE-627)DOAJ088827224 (DE-599)DOAJ900b9bc74c4646cabf2df89ae6f8dd96 DE-627 ger DE-627 rakwb eng RC581-607 Saori Nagashima verfasserin aut Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs. Eosinophilic duodenitis (EoD) Eosinophilic gastrointestinal disorders (EGID, EGIDs) Eosinophilic gastritis (EoG) Elimination diet (ED) Non-IgE-mediated gastrointestinal food allergy Immunologic diseases. Allergy Mayu Yamamoto verfasserin aut Yusuke Inuzuka verfasserin aut Makoto Irahara verfasserin aut Yumiko Miyaji verfasserin aut Hiromi Tadaki verfasserin aut Shuichi Ito verfasserin aut Shizuka Masuda verfasserin aut Yoshiyuki Ito verfasserin aut Yuri Saito verfasserin aut Saeko Kobayashi verfasserin aut Hideaki Morita verfasserin aut Takako Yoshioka verfasserin aut Hirotaka Shimizu verfasserin aut Katsuhiro Arai verfasserin aut Yukihiro Ohya verfasserin aut Hirohisa Saito verfasserin aut Kenji Matsumoto verfasserin aut Ichiro Nomura verfasserin aut In Allergology International Elsevier, 2002 72(2023), 2, Seite 306-315 (DE-627)320425320 (DE-600)2003098-8 14401592 nnns volume:72 year:2023 number:2 pages:306-315 https://doi.org/10.1016/j.alit.2022.11.001 kostenfrei https://doaj.org/article/900b9bc74c4646cabf2df89ae6f8dd96 kostenfrei http://www.sciencedirect.com/science/article/pii/S1323893022001265 kostenfrei https://doaj.org/toc/1323-8930 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 72 2023 2 306-315
allfieldsSound	10.1016/j.alit.2022.11.001 doi (DE-627)DOAJ088827224 (DE-599)DOAJ900b9bc74c4646cabf2df89ae6f8dd96 DE-627 ger DE-627 rakwb eng RC581-607 Saori Nagashima verfasserin aut Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs. Eosinophilic duodenitis (EoD) Eosinophilic gastrointestinal disorders (EGID, EGIDs) Eosinophilic gastritis (EoG) Elimination diet (ED) Non-IgE-mediated gastrointestinal food allergy Immunologic diseases. Allergy Mayu Yamamoto verfasserin aut Yusuke Inuzuka verfasserin aut Makoto Irahara verfasserin aut Yumiko Miyaji verfasserin aut Hiromi Tadaki verfasserin aut Shuichi Ito verfasserin aut Shizuka Masuda verfasserin aut Yoshiyuki Ito verfasserin aut Yuri Saito verfasserin aut Saeko Kobayashi verfasserin aut Hideaki Morita verfasserin aut Takako Yoshioka verfasserin aut Hirotaka Shimizu verfasserin aut Katsuhiro Arai verfasserin aut Yukihiro Ohya verfasserin aut Hirohisa Saito verfasserin aut Kenji Matsumoto verfasserin aut Ichiro Nomura verfasserin aut In Allergology International Elsevier, 2002 72(2023), 2, Seite 306-315 (DE-627)320425320 (DE-600)2003098-8 14401592 nnns volume:72 year:2023 number:2 pages:306-315 https://doi.org/10.1016/j.alit.2022.11.001 kostenfrei https://doaj.org/article/900b9bc74c4646cabf2df89ae6f8dd96 kostenfrei http://www.sciencedirect.com/science/article/pii/S1323893022001265 kostenfrei https://doaj.org/toc/1323-8930 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 72 2023 2 306-315
language	English
source	In Allergology International 72(2023), 2, Seite 306-315 volume:72 year:2023 number:2 pages:306-315
sourceStr	In Allergology International 72(2023), 2, Seite 306-315 volume:72 year:2023 number:2 pages:306-315
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Eosinophilic duodenitis (EoD) Eosinophilic gastrointestinal disorders (EGID, EGIDs) Eosinophilic gastritis (EoG) Elimination diet (ED) Non-IgE-mediated gastrointestinal food allergy Immunologic diseases. Allergy
isfreeaccess_bool	true
container_title	Allergology International
authorswithroles_txt_mv	Saori Nagashima @@aut@@ Mayu Yamamoto @@aut@@ Yusuke Inuzuka @@aut@@ Makoto Irahara @@aut@@ Yumiko Miyaji @@aut@@ Hiromi Tadaki @@aut@@ Shuichi Ito @@aut@@ Shizuka Masuda @@aut@@ Yoshiyuki Ito @@aut@@ Yuri Saito @@aut@@ Saeko Kobayashi @@aut@@ Hideaki Morita @@aut@@ Takako Yoshioka @@aut@@ Hirotaka Shimizu @@aut@@ Katsuhiro Arai @@aut@@ Yukihiro Ohya @@aut@@ Hirohisa Saito @@aut@@ Kenji Matsumoto @@aut@@ Ichiro Nomura @@aut@@
publishDateDaySort_date	2023-01-01T00:00:00Z
hierarchy_top_id	320425320
id	DOAJ088827224
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ088827224</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230501183740.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230410s2023 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.alit.2022.11.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ088827224</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ900b9bc74c4646cabf2df89ae6f8dd96</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC581-607</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Saori Nagashima</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Eosinophilic duodenitis (EoD)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Eosinophilic gastrointestinal disorders (EGID, EGIDs)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Eosinophilic gastritis (EoG)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Elimination diet (ED)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Non-IgE-mediated gastrointestinal food allergy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Immunologic diseases. Allergy</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mayu Yamamoto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yusuke Inuzuka</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Makoto Irahara</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yumiko Miyaji</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hiromi Tadaki</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shuichi Ito</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shizuka Masuda</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yoshiyuki Ito</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yuri Saito</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Saeko Kobayashi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hideaki Morita</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Takako Yoshioka</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hirotaka Shimizu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katsuhiro Arai</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yukihiro Ohya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hirohisa Saito</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kenji Matsumoto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ichiro Nomura</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Allergology International</subfield><subfield code="d">Elsevier, 2002</subfield><subfield code="g">72(2023), 2, Seite 306-315</subfield><subfield code="w">(DE-627)320425320</subfield><subfield code="w">(DE-600)2003098-8</subfield><subfield code="x">14401592</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:72</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:306-315</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.alit.2022.11.001</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/900b9bc74c4646cabf2df89ae6f8dd96</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S1323893022001265</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1323-8930</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">72</subfield><subfield code="j">2023</subfield><subfield code="e">2</subfield><subfield code="h">306-315</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Saori Nagashima
spellingShingle	Saori Nagashima misc RC581-607 misc Eosinophilic duodenitis (EoD) misc Eosinophilic gastrointestinal disorders (EGID, EGIDs) misc Eosinophilic gastritis (EoG) misc Elimination diet (ED) misc Non-IgE-mediated gastrointestinal food allergy misc Immunologic diseases. Allergy Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis
authorStr	Saori Nagashima
ppnlink_with_tag_str_mv	@@773@@(DE-627)320425320
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC581-607
illustrated	Not Illustrated
issn	14401592
topic_title	RC581-607 Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis Eosinophilic duodenitis (EoD) Eosinophilic gastrointestinal disorders (EGID, EGIDs) Eosinophilic gastritis (EoG) Elimination diet (ED) Non-IgE-mediated gastrointestinal food allergy
topic	misc RC581-607 misc Eosinophilic duodenitis (EoD) misc Eosinophilic gastrointestinal disorders (EGID, EGIDs) misc Eosinophilic gastritis (EoG) misc Elimination diet (ED) misc Non-IgE-mediated gastrointestinal food allergy misc Immunologic diseases. Allergy
topic_unstemmed	misc RC581-607 misc Eosinophilic duodenitis (EoD) misc Eosinophilic gastrointestinal disorders (EGID, EGIDs) misc Eosinophilic gastritis (EoG) misc Elimination diet (ED) misc Non-IgE-mediated gastrointestinal food allergy misc Immunologic diseases. Allergy
topic_browse	misc RC581-607 misc Eosinophilic duodenitis (EoD) misc Eosinophilic gastrointestinal disorders (EGID, EGIDs) misc Eosinophilic gastritis (EoG) misc Elimination diet (ED) misc Non-IgE-mediated gastrointestinal food allergy misc Immunologic diseases. Allergy
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Allergology International
hierarchy_parent_id	320425320
hierarchy_top_title	Allergology International
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)320425320 (DE-600)2003098-8
title	Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis
ctrlnum	(DE-627)DOAJ088827224 (DE-599)DOAJ900b9bc74c4646cabf2df89ae6f8dd96
title_full	Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis
author_sort	Saori Nagashima
journal	Allergology International
journalStr	Allergology International
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2023
contenttype_str_mv	txt
container_start_page	306
author_browse	Saori Nagashima Mayu Yamamoto Yusuke Inuzuka Makoto Irahara Yumiko Miyaji Hiromi Tadaki Shuichi Ito Shizuka Masuda Yoshiyuki Ito Yuri Saito Saeko Kobayashi Hideaki Morita Takako Yoshioka Hirotaka Shimizu Katsuhiro Arai Yukihiro Ohya Hirohisa Saito Kenji Matsumoto Ichiro Nomura
container_volume	72
class	RC581-607
format_se	Elektronische Aufsätze
author-letter	Saori Nagashima
doi_str_mv	10.1016/j.alit.2022.11.001
author2-role	verfasserin
title_sort	tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis
callnumber	RC581-607
title_auth	Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis
abstract	Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs.
abstractGer	Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs.
abstract_unstemmed	Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	2
title_short	Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis
url	https://doi.org/10.1016/j.alit.2022.11.001 https://doaj.org/article/900b9bc74c4646cabf2df89ae6f8dd96 http://www.sciencedirect.com/science/article/pii/S1323893022001265 https://doaj.org/toc/1323-8930
remote_bool	true
author2	Mayu Yamamoto Yusuke Inuzuka Makoto Irahara Yumiko Miyaji Hiromi Tadaki Shuichi Ito Shizuka Masuda Yoshiyuki Ito Yuri Saito Saeko Kobayashi Hideaki Morita Takako Yoshioka Hirotaka Shimizu Katsuhiro Arai Yukihiro Ohya Hirohisa Saito Kenji Matsumoto Ichiro Nomura
author2Str	Mayu Yamamoto Yusuke Inuzuka Makoto Irahara Yumiko Miyaji Hiromi Tadaki Shuichi Ito Shizuka Masuda Yoshiyuki Ito Yuri Saito Saeko Kobayashi Hideaki Morita Takako Yoshioka Hirotaka Shimizu Katsuhiro Arai Yukihiro Ohya Hirohisa Saito Kenji Matsumoto Ichiro Nomura
ppnlink	320425320
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1016/j.alit.2022.11.001
callnumber-a	RC581-607
up_date	2024-07-03T19:44:00.730Z
_version_	1803588301735591936
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ088827224</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230501183740.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230410s2023 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.alit.2022.11.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ088827224</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ900b9bc74c4646cabf2df89ae6f8dd96</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC581-607</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Saori Nagashima</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) are chronic inflammatory disorders with massive infiltration of eosinophils into the gastrointestinal tract. Food elimination diets are potentially effective treatments. But the existing dietary therapies have various weak points. We developed a new regimen to compensate for the shortcomings of the elemental diet and 6-food elimination diet. The new regimen consists of an amino-acid-based formula, potatoes, vegetables, fruits and restricted seasonings. We named it the “Rainbow Elimination Diet (ED).” The aims of this study were to evaluate the tolerability and safety of this diet. Methods: A retrospective medical record examination was conducted at the National Center for Child Health and Development covering the period from January 2010 through December 2018. The medical records of patients (age 2–17 y) with histologically diagnosed non-EoE EGIDs were reviewed. The tolerability, nutritional intake, symptoms, and blood test findings were evaluated. Results: Nineteen patients were offered several kinds of food-elimination diets. Seven patients (eosinophilic gastritis: 5; gastroenteritis: 1; duodenitis: 1) were treated with Rainbow ED. Six patients were compliant with this diet. The median duration of the diet induction phase was 15 days (range 14–30). All 5 patients who had had symptoms just before the induction phase became symptom-free. The body weight decreased in 5 patients (median −0.6 kg), probably because the serum protein increased, resulting in reduced edema. All 5 patients with hypoproteinemia had elevated serum albumin (median 2.9–3.5 g/dL). The ingested nutritional elements were calculated, and most of them were sufficient, except for fat and selenium. Conclusions: The Rainbow ED was well-tolerated and safe for pediatric non-EoE EGIDs.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Eosinophilic duodenitis (EoD)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Eosinophilic gastrointestinal disorders (EGID, EGIDs)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Eosinophilic gastritis (EoG)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Elimination diet (ED)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Non-IgE-mediated gastrointestinal food allergy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Immunologic diseases. Allergy</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mayu Yamamoto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yusuke Inuzuka</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Makoto Irahara</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yumiko Miyaji</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hiromi Tadaki</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shuichi Ito</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shizuka Masuda</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yoshiyuki Ito</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yuri Saito</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Saeko Kobayashi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hideaki Morita</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Takako Yoshioka</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hirotaka Shimizu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katsuhiro Arai</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Yukihiro Ohya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hirohisa Saito</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kenji Matsumoto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ichiro Nomura</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Allergology International</subfield><subfield code="d">Elsevier, 2002</subfield><subfield code="g">72(2023), 2, Seite 306-315</subfield><subfield code="w">(DE-627)320425320</subfield><subfield code="w">(DE-600)2003098-8</subfield><subfield code="x">14401592</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:72</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:306-315</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.alit.2022.11.001</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/900b9bc74c4646cabf2df89ae6f8dd96</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S1323893022001265</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1323-8930</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">72</subfield><subfield code="j">2023</subfield><subfield code="e">2</subfield><subfield code="h">306-315</subfield></datafield></record></collection>
score	7.39931

Nicht das Richtige dabei?

Schreiben Sie uns!

Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?